Neurogene Inc.
NGNE
$17.16
$0.362.14%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.33% | -9.28% | -810.07% | 116.35% | -22.91% |
| Total Depreciation and Amortization | -1.22% | -0.97% | -0.36% | 0.00% | 0.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.79% | 122.68% | 107.50% | -2,976.17% | 1.09% |
| Change in Net Operating Assets | 391.58% | 86.98% | -58.84% | -361.16% | 40.02% |
| Cash from Operations | 2.07% | 26.59% | -27.56% | -46.72% | -24.03% |
| Capital Expenditure | 63.70% | -607.69% | 49.22% | -56.10% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.38% | -177.18% | 500.00% | -- | -- |
| Cash from Investing | -22.66% | -178.88% | 15.89% | 31,600.00% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 25.00% | -45.45% | -37.50% | 20.00% | -66.67% |
| Issuance of Common Stock | -65.54% | -34.02% | 62,800.00% | -97.14% | 75.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -107.57% | 5,167.38% | -1,761.00% |
| Cash from Financing | -67.17% | 106.12% | -106.92% | 5,236.00% | -2,034.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.53% | -2,320.78% | -98.29% | 864.90% | -42.03% |
